Zenas Biopharma, Inc. (ZBIO) Stock Price & Analysis
Zenas Biopharma, Inc. (ZBIO) rose 0.00% to USD 30.39 as of July 25, 2026 at 04:38 UTC, according to Nexqual real-time market data.
ZBIO last closed at USD 30.39; the session ranged USD 30.09–31.3 on volume of 558,939 shares. Market capitalization is —, with a 52-week range of USD 13.5–44.6 (NMS). Source: Nexqual, July 25, 2026 at 04:38 UTC.
Key Statistics (as of July 25, 2026 at 04:38 UTC)
| Price | USD 30.39 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 30.39 |
| Open | USD 30.39 |
| Day Range | USD 30.09 – 31.3 |
| 52-Week Range | USD 13.5 – 44.6 |
| Volume | 558,939 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (ZBIO)
Nexqual's technical model rates ZBIO "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 04:38 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 65.01 (neutral) |
| vs SMA50 | Above (USD 22.79) |
| MACD | 2.41 (positive) |
From Zenas Biopharma, Inc.'s Latest SEC 10-K Filing (filed 2026-03-16)
Key Strengths & Strategy (as disclosed to the SEC)
- We also intend to submit a Marketing Authorization Application ("MAA") to the European Medicines Agency ("EMA") in the second half of 2026.
Partnerships
- In addition, in October 2024, we entered into a novation agreement with Tenacia Biotechnology (Hong Kong) Co., Limited ("Tenacia"), under which we transferred to Tenacia our rights and obligations under our agreements with Dianthus Therapeutics Inc. ("Dianthus") for ZB005 (the "Tenacia Agreement").
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MBX | MBX Biosciences, Inc. | USD 62 | ▲ 6.35% |
| BCAX | Bicara Therapeutics Inc. | USD 27.02 | ▼ 3.36% |
| UPB | Upstream Bio, Inc. | USD 6.41 | ▼ 2.73% |
| ALMS | Alumis Inc. | USD 28 | ▼ 2.81% |
| RAPP | Rapport Therapeutics, Inc. | USD 40.68 | ▼ 1.57% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:38 UTC. This page is informational and not investment advice.